The Third Injection Technique Workshop in Athens (TITAN);Troisième atelier sur la technique des injections à Athènes (TITAN).

Diabetes and Metabolism

Volumn 36, Issue SUPPL. 1, 2010, Pages

  Frid, A ^a   Hirsch, L ^b   Gaspar, R ^c   Hicks, D ^d   Kreugel, G ^e   Liersch, J ^f   Letondeur, C ^g   Sauvanet, J P ^h   Tubiana Rufi, N ⁱ   Strauss, K ^j  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Endocrinologist   (United States)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Diabetes Specialty Nurse   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

^g Diabetes Education Manager   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ HÔPITAL ROBERT DEBRÉ   (France)

^j Endocrinologist   (Belgium)

more..

Author keywords

Complications; Diabetes mellitus; GLP 1 analogs; Injections; Insulin; Insulin therapy; Lipohypertrophy; Needles; Recommendations; Review; Subcutaneous tissue; Technical aspects; Treatment

Indexed keywords

INSULIN; INSULIN GLARGINE; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; DIABETES MELLITUS; GLYCEMIC CONTROL; GREECE; HEALTH CARE PERSONNEL; HUMAN; INJECTION SITE; INSULIN PUMP; INSULIN TREATMENT; LIPOHYPERTROPHY; NEEDLE; NETHERLANDS; OBESITY; PREGNANT WOMAN; SKINFOLD; SPAIN; SUBCUTANEOUS FAT; SUBCUTANEOUS TISSUE; UNITED STATES; WESTERN EUROPE; WORKSHOP; CLINICAL TRIAL; EVIDENCE BASED PRACTICE; GLUCOSE BLOOD LEVEL; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL PRACTICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREGNANCY; PSYCHOLOGICAL ASPECT; SKINFOLD THICKNESS; SYRINGE;

BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DRUG STORAGE; EQUIPMENT DESIGN; EUROPE; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; FEMALE; GREAT BRITAIN; HUMANS; HYPERTROPHY; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; NEEDLES; NEEDLESTICK INJURIES; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; SUBCUTANEOUS FAT, ABDOMINAL; SYRINGES; UNITED STATES;

EID: 77957712327     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(10)70003-3     Document Type: Article

References (57)

1. Strauss K. Insulin injection techniques: Report from the 1st International Insulin Injection Technique Workshop, Strasbourg, France-June 1997. Pract Diabetes Int 1998, 15:16-20.
2. Strauss K., De Gols H., Letondeur C., Matyjaszczyk M., Frid A. The second injection technique event (SITE), May 2000, Barcelona, Spain. Pract Diabetes Int 2002, 19:17-21.
3. Strauss K., De Gols H., Hannet I., Partanen T.M., Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diabetes Int 2002, 19:71-76.
4. Binder C. Absorption of injected insulin. A clinical-pharmacological study. Acta Pharmacol Toxicol (Copenh) 1969, 27:1-84.
5. Frid A., Lindén B. Where do lean diabetics inject their insulin? A study using computed tomography. BMJ 1986, 292:1638.
6. De Meijer P.H.E.M., Lutterman J.A., van Lier H.J.J., van't Laar A. The variability of the absorption of subcutaneously injected insulin; effect of injection technique and relation with brittleness. Diabet Med 1990, 7:499-505.
7. Frid A., Gunnarsson R., Güntner P., Linde B. Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care 1988, 11:41-45.
8. Frid A., Östman J., Linde B. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care 1990, 13:473-477.
9. Clauson P.G., Linde B. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Diabetes Care 1995, 18:986-991.
10. Frid A., Lindén B. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 1992, 9:236-239.
11. Frid A, Linden B. Computed tomography of injection sites in patients with diabetes mellitus. In: Injection and Absorption of Insulin. Thesis, Stockholm, 1992.
12. Frid A. Fat thickness and insulin administration, what do we know?. Infusystems International 2006, 5:17-19.
13. Mudaliar S.R., Lindberg F.A., Joyce M., Beerdsen P., Strange P., Lin A., et al. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 1999, 22:1501-1506.
14. Rave K., Heise T., Weyer C., Herrnberger J., Bender R., Hirschberger S., et al. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Diabet Med 1998, 15:747-751.
15. Guerci B., Sauvanet J.P. Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabetes Metab 2005, 31. 4S7-4S24.
16. Braakter E.W., Woodworth J.R., Bianchi R., Cermele B., Erkelens D.W., Thijssen J.H., et al. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care 1996, 19:1437-1440.
17. Rave K., Heise T., Weyer C., Herrnberger J., Bender R., Hirschberger S., et al. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Diabet Med 1998, 15:747-751.
18. Henriksen J.E., Vaag A., Hansen I.R., Lauritzen M., Djurhuus M.S., Beck-Nielsen H. Absorption of NPH (isophane) insulin in resting diabetic patients; evidence for subcutaneous injection in the thigh as preferred site. Diabet Med 1991, 8:453-457.
19. Owens D.R., Coates P.A., Luzio S.D., Tinbergen J.P., Kurzhals R. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 2000, 23:813-819.
20. Diabetes Atlas, International Diabetes Federation. Available at: http://www.diabetesatlas.org/.
21. Echeverry D., Duran P., Bonds C., Lee M., Davidson M.B. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2009, 32:2156-2160.
22. Case S., Jernigan V., Gardner A., Ritter P., Heaney C.A., Lorig K.R. Content and frequency of writing on diabetes bulletin boards: does race make a difference?. J Med Internet Res 2009, 11:e22.
23. Cefalu W.T., Mathieu C., Davidson J., Freemantle N., Gough S., Canovatchel W. Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol Ther 2008, 10:25-38. OPTIMIZE Coalition.
24. Roper data, exclusive property of GFK Healthcare.
25. Tubiana-Rufi N., Belarbi N., du Pasquier-Fediaevsky L., Polak M., Kakou B., Leridon L., et al. Short needles (8mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999, 22:1621-1625.
26. Nielsen BB, Musaeus L, Gæde P, Steno Diabetes Center, Copenhagen, Denmark. Attention to injection technique is associated with a lower frequency of lipohypertrophy in insulin treated type 2 diabetic patients. Abstract EASD1998, Barcelona, Spain, Diabetologia 1998.
27. Association for Diabetescare Professionals (EADV). Guideline: The Administration of Insulin with the Insulin Pen. September 2008. Access via: http://www.eadv.nl/.
28. Danish Nurses Organization. Evidence-based Clinical Guidelines for Injection of Insulin for Adults with Diabetes Mellitus, 2nd edition, December 2006. Access via: http://www.dsr.dk/.
29. Bärtsch U., Comtesse C., Wetekam B. Insulin pens for treatment of diabetes (article in German). Ther Umsch 2006, 63:398-404.
30. Joy S.V. Clinical pearls and strategies to optimize patient outcomes. Diabetes Educ 2008, 34:54S-59S.
31. King L. Subcutaneous insulin injection technique. Nurs Stand 2003, 17:45-52.
32. Partanen T.M., Rissanen A. Insulin injection practices. Pract Diabetes Int 2000, 17:252-254.
33. Laurent A., Mistretta F., Bottigioli D., Dahel K., Goujon C., Nicolas J.F., Hennino A., et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007, 25:6423-6430.
34. Lasagni C., Seidenari S. Echographic assessment of age-dependent variations of skin thickness. Skin Res Technol 1995, 1:81-85.
35. Swindle L.D., Thomas S.G., Freeman M., Delaney P.M. View of Normal Human Skin In Vivo as Observed Using Fluorescent Fiber-Optic Confocal Microscopic Imaging. J Invest Dermatol 2003, 121:706-712.
36. Huzaira M., Rius F., Rajadhyaksha M., Anderson R.R., González S. Topographic Variations in Normal Skin, as Viewed by In Vivo Reflectance Confocal Microscopy. J Invest Dermatol 2001, 116:846-852.
37. Tan C.Y., Statham B., Marks R., Payne P.A. Skin thickness measured by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982, 106:657-667.
38. Engström L., Jinnerot H., Jonasson E. Thickness of Subcutaneous Fat Tissue Where Pregnant Diabetics Inject Their Insulin - An Ultrasound Study. Poster at IDF 17th World Diabetes Congress 2000.
39. Guerci B., Sauvanet J.-P. Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabetes Metab 2005, 31. 4S7-4S24.
40. Klein O., Lynge J., Endahl L., Damholt B., Nosek L., Heise T. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes. Diabetes Obes Metab 2007, 9:290-299.
41. Schmeisl GW. Investigation of coincidences between injection practice, blood glucose excursions and frequency of lipohypertrophy during insulin therapy. (Published in German) Diabetes, Metabolism and the Heart 2009;18:251-8.
42. De Villiers F.P. Lipohypertrophy - a complication of insulin injections. S Afr Med J 2005, 95:858-859.
43. Overland J., Molyneaux L., Tewari S., Fatouros R., Melville P., Foote D., et al. Lipohypertrophy: Does it matter in daily life? A study using a continuous glucose monitoring system. Diabetes Obes Metab 2009, 11:460-463.
44. Hauner H., Stockamp B., Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes 1996, 104:106-110.
45. Vardar B., Kizilci S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract 2007, 77:231-236.
46. Byetta Pen User Manual. Eli Lilly and Company, 2007.
47. Bohannon N.J. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999, 106:57-58.
48. Bärtsch U., Comtesse C., Wetekam B. Insulin pens for treatment of diabetes (article in German). Ther Umsch 2006, 63:398-404.
49. Klonoff D.C. The pen is mightier than the needle (and syringe). Diabetes Technol Ther 2001, 3:631-633.
50. Kreugel G., Keers J.C., Jongbloed A., Verweij-Gjaltema A.H., Wolffenbuttel B.H.R. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes 2009, 58:A117.
51. Ogundipe O, Blandford R, Ogundipe O. A Survey of the Impact of Insulin-Treated Diabetes on Employment. Internet J Endocrinol 2006; 2 http://www.ispub.com/journal/the_internet_journal_of_endocrinology/volum e_2_number_2_16/article/a_survey_of_the_impact_of_insulin_treated_diabet es_on_employment.html.
52. Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab 2008, 34:382-385.
53. Polonsky W.H., Jackson R. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes 2004, 22:147-150.
54. Polonsky W.H., Fisher L., Guzman S., Villa-Caballero L., Edelman S.V. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005, 28:2543-2545.
55. Martinez L., Consoli S.M., Monnier L., Simon D., Wong O., Yomtov B., et al. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. Health Qual Life Outcomes 2007, 5:53.
56. Cocoman A., Barron C. Administering subcutaneous injections to children: what does the evidence say?. Journal of Children and Young People's Nursing 2008, 2:84-89.
57. Saez-de Ibarra L., Gallego F. Factors related to lipohypertrophy in insulin-treated diabetic patients; role of educational intervention. Pract Diabetes Int 1998, 15:9-11.